BioVersys AG (SWX:BIOV)
Switzerland · Delayed Price · Currency is CHF 27.50
-0.10 (-0.36%)
At close: Jul 10, 2026
BioVersys AG Market Cap
BioVersys AG has a market cap or net worth of 161 million as of July 10, 2026. Its market cap has decreased by -22.99% in one year.
Market Cap
161.00M
Enterprise Value
100.23M
Revenue
3.18M
Ranking
n/a
PE Ratio
n/a
Stock Price
27.50
Market Cap Chart
Since February 6, 2025, BioVersys AG's market cap has decreased from 207.92M to 161.00M, a decrease of -22.57%. That is a compound annual growth rate of -16.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 161.00M | 12.83% |
| Dec 30, 2025 | 142.69M | -31.37% |
| Feb 6, 2025 | 207.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bachem Holding AG | 5.61B |
| Idorsia | 1.58B |
| Basilea Pharmaceutica AG | 681.77M |
| Newron Pharmaceuticals | 245.51M |
| Santhera Pharmaceuticals Holding AG | 227.94M |
| Molecular Partners AG | 120.41M |
| Xlife Sciences AG | 102.64M |
| MindMaze Therapeutics Holding | 27.47M |